Prestige Financial Statements From 2010 to 2025
| PBV Stock | EUR 71.00 2.00 2.74% |
Check Prestige Consumer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Prestige Consumer's main balance sheet or income statement drivers, such as , as well as many indicators such as . Prestige financial statements analysis is a perfect complement when working with Prestige Consumer Valuation or Volatility modules.
Prestige |
Prestige Consumer Healthcare Company Return On Equity Analysis
Prestige Consumer's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Prestige Consumer Return On Equity | 0.13 |
Most of Prestige Consumer's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Prestige Consumer Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Prestige Consumer Healthcare has a Return On Equity of 0.1312. This is 100.55% lower than that of the Healthcare sector and 98.24% lower than that of the Medical Distribution industry. The return on equity for all Germany stocks is 142.32% lower than that of the firm.
Prestige Consumer Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Prestige Consumer's current stock value. Our valuation model uses many indicators to compare Prestige Consumer value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Prestige Consumer competition to find correlations between indicators driving Prestige Consumer's intrinsic value. More Info.Prestige Consumer Healthcare is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Prestige Consumer Healthcare is roughly 2.28 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Prestige Consumer's earnings, one of the primary drivers of an investment's value.About Prestige Consumer Financial Statements
Prestige Consumer stakeholders use historical fundamental indicators, such as Prestige Consumer's revenue or net income, to determine how well the company is positioned to perform in the future. Although Prestige Consumer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Prestige Consumer's assets and liabilities are reflected in the revenues and expenses on Prestige Consumer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Prestige Consumer Healthcare. Please read more on our technical analysis and fundamental analysis pages.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter healthcare products in North America, Australia, and internationally. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. PRESTIGE CONS operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 520 people.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Prestige Stock
Prestige Consumer financial ratios help investors to determine whether Prestige Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Prestige with respect to the benefits of owning Prestige Consumer security.